Rosenthal–Kloepfer syndrome
Rosenthal–Kloepfer syndrome is a rare genetic disorder characterized by albinism, deafness, and mental retardation. The syndrome was first described by Rosenthal and Kloepfer in 1960.
Symptoms and Signs[edit | edit source]
The main symptoms of Rosenthal–Kloepfer syndrome include:
- Albinism: This is a condition characterized by a lack of pigment in the skin, hair, and eyes. People with albinism often have vision problems and are at increased risk of skin cancer.
- Deafness: This is a loss of hearing that can be partial or total. It can be present at birth or develop later in life.
- Mental retardation: This is a term used to describe below-average intelligence and set of life skills. It is usually present from birth.
Causes[edit | edit source]
Rosenthal–Kloepfer syndrome is a genetic disorder, which means it is caused by abnormalities in the genes. It is thought to be inherited in an autosomal recessive manner, which means both parents must carry a copy of the faulty gene for a child to be affected.
Diagnosis[edit | edit source]
The diagnosis of Rosenthal–Kloepfer syndrome is based on the presence of the characteristic symptoms. Genetic testing can confirm the diagnosis.
Treatment[edit | edit source]
There is no cure for Rosenthal–Kloepfer syndrome. Treatment is aimed at managing the symptoms and improving the quality of life. This may include:
- Skin care to protect against sun damage
- Hearing aids or cochlear implants to improve hearing
- Special education and therapy to help with mental retardation
Prognosis[edit | edit source]
The prognosis for individuals with Rosenthal–Kloepfer syndrome varies. Some people may have a normal lifespan, while others may have a shortened lifespan due to complications of the disorder.
See also[edit | edit source]
Rosenthal–Kloepfer syndrome Resources | ||
---|---|---|
|
|
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD